Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 07, 2024.
All times in Eastern Daylight Time.
-
TotalEnergies et SINOPEC renforcent leur coopérationPARIS--(BUSINESS WIRE)--Regulatory News: A l’occasion de la visite d’Etat en France du Président de la République Populaire de Chine, TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE), représenté par ... more »
-
TotalEnergies and SINOPEC Strengthen CooperationPARIS--(BUSINESS WIRE)--Regulatory News: On the occasion of the state visit to France by the President of the People's Republic of China, TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE), represented... more »
-
PARIS--(BUSINESS WIRE)-- On the occasion of the state visit to France by the President of the People's Republic of China, TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE), represented by Patrick Pou... more »
-
First Surgeries Using Stryker’s Infinity With Adaptis and Everlast Successfully Completed in EuropeAMSTERDAM--(BUSINESS WIRE)--Stryker announced the completion of the first European surgeries using the Infinity Total Ankle System with Adaptis and Everlast technology. more »
-
LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (“Faraday Future” or the “Company”) (NASDAQ: FFIE), a California-based global shared intelligent electric mobility ecosystem c... more »
-
Modalis Therapeutics Reports Data Supporting Development of a Transformative Epigenome Editing Therapeutic, MDL-101: a First-in-Class Epigenome Editing approach for the Treatment of LAMA2-deficient congenital muscular dystrophy (LAMA2-CMD)TOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--Modalis Therapeutics Corporation (Tokyo Stock Exchange: 4883), a pioneering company developing innovative drugs for the treatment of rare genetic diseases, ... more »
-
LONDON--(BUSINESS WIRE)-- Commonwealth Bank of Australia Issue of GBP 100,000,000.00 Floating Rate Notes due 12 November 2024 Series 6560 Tranche 1 MTN ISSUE NAME. Our Ref. MQ2458 ISIN Code. XS271... more »
-
LONDON--(BUSINESS WIRE)-- Santander UK PLC Issue of GBP 1,000,000,000.00 Floating Rate Covered Bond due 12 November 2024 Series 73 Tranche 1 ISSUE NAME. Our Ref. MM3366 ISIN Code. XS2078925307 TOT... more »
-
LONDON--(BUSINESS WIRE)-- Commonwealth Bank of Australia Issue of GBP 100,000,000.00 Floating Rate Notes due 12 November 2024 Series 6559 Tranche 1 MTN ISSUE NAME. Our Ref. MQ2449 ISIN Code. XS271... more »
-
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (th... more »
-
LONDON--(BUSINESS WIRE)-- Commonwealth Bank of Australia Issue of GBP 325,000,000.00 Floating Rate Notes due November 2024 Series 6563 Tranche 1 MTN ISSUE NAME. Our Ref. MQ2532 ISIN Code. XS271729... more »
-
LONDON--(BUSINESS WIRE)-- FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH IN... more »
-
LONDON--(BUSINESS WIRE)-- POST-STABILISATION ANNOUNCEMENT Date: 6th May, 2024 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribut... more »
-
Getlink: Shuttle Traffic in April 2024PARIS--(BUSINESS WIRE)--Regulatory News: Getlink SE (Paris:GET): April 24 April 23 Change Jan-April 2024 Jan-April 2023 Change Truck Shuttles Trucks 101,250 98,737 3% 403,051 420,641 -4% Passen... more »
-
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (th... more »